11/7
09:51 am
ipsc
Century Therapeutics, Inc. (NASDAQ: IPSC) had its price target lowered by analysts at Chardan Capital from $17.00 to $11.00. They now have a "buy" rating on the stock.
Low
Report
Century Therapeutics, Inc. (NASDAQ: IPSC) had its price target lowered by analysts at Chardan Capital from $17.00 to $11.00. They now have a "buy" rating on the stock.
11/6
08:07 am
ipsc
Century Therapeutics, Inc. (NASDAQ: IPSC) had its price target lowered by analysts at HC Wainwright from $9.00 to $5.00. They now have a "buy" rating on the stock.
Medium
Report
Century Therapeutics, Inc. (NASDAQ: IPSC) had its price target lowered by analysts at HC Wainwright from $9.00 to $5.00. They now have a "buy" rating on the stock.
11/6
08:05 am
ipsc
Century Therapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
Medium
Report
Century Therapeutics Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]
11/5
12:13 pm
ipsc
Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Century Therapeutics, Inc. (IPSC) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
11/5
09:14 am
ipsc
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
Medium
Report
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates [Yahoo! Finance]
11/5
09:05 am
ipsc
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
Medium
Report
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
11/5
09:00 am
ipsc
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
Medium
Report
Century Therapeutics Announces Upcoming Poster Presentations at the 2024 American Society of Hematology (ASH) Annual Meeting
11/4
07:00 am
ipsc
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
Medium
Report
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
10/28
03:52 pm
ipsc
We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate [Yahoo! Finance]
Low
Report
We're A Little Worried About Century Therapeutics' (NASDAQ:IPSC) Cash Burn Rate [Yahoo! Finance]
10/22
11:53 am
ipsc
electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar? [Yahoo! Finance]
Medium
Report
electroCore (ECOR) Stock Jumps 11.7%: Will It Continue to Soar? [Yahoo! Finance]
10/2
11:08 am
ipsc
Regenerative Medicine Market to Reach $37.27 Billion by 2031, Driven by the Growing Number of New Regenerative Medicine Approvals and Consistent Advancements in the Regenerative Medicine Space - Exclusive Report by Meticulous Research® [Yahoo! Finance]
Low
Report
Regenerative Medicine Market to Reach $37.27 Billion by 2031, Driven by the Growing Number of New Regenerative Medicine Approvals and Consistent Advancements in the Regenerative Medicine Space - Exclusive Report by Meticulous Research® [Yahoo! Finance]
9/26
07:00 am
ipsc
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer
Low
Report
Century Therapeutics Strengthens Leadership Team with Appointments of Chief Financial Officer and Chief Scientific Officer